Innovation in the commercialization of new medicines: the 4 pillars from the Marketing Authorization to Market Access
This is a Workshop in which the speakers are representative of the four pillars: evaluation and authorization of the medicinal product, represented by the The Spanish Agency of Medicines and Medical Devices (AEMPS) with the Spanish representative from the Committee of Advanced Therapies (CAT), the Hospital Drug Product Access through the Pharmacotherapeutic Guidelines with a representative of the Spanish Society of Hospital Pharmacy (SEFH), the Market Access from the pharmaceutical industry, with a Responsible of a Department of Pharmacoeconomics in BMS and the Regulatory Affairs with a Qualified Person and RA Director from Mundipharma.
The moderator of the table is one of the leaders in the world of Pharma Market Access, Health Economics and Outcomes Reseach/Pricing and Reimbursement, with extended teaching experience:
-Jose Manuel Rodriguez Barrios. Health Economics, Pricing and Market Access Strategy Europe Director, Daiichi Sankyo Europe.
KEYWORDS & TOPICS
Presentador – Moderador:
Speaker: José Manuel Rodriguez Barrios
Institution: Economics, Pricing and Market Access Strategy Director Europe, Daiichi Sankyo Europe.
Title: First of the 4 pillars: Innovation in Marketing Authorizations.
Speaker: Marcos Timón
Institution: AEMPS. – Alternate member at the Committe for Advanced Therapies / Member of the BWP.
Title: Second pillar from Marketing Authorization to Market Access: evidence generation from HEOR.
Speaker: Paloma González
Institution: Strategic account & Business Development Lead – Hologic, Inc.
Title: Pricing and Market Access Strategy from Pharma industry: the third pillar.
Speaker: Mª José Sancho González
Institution: QP and Regulatory Affairs Director – Mundipharma.
Title: The fourth pillar from Marketing Authorization to Market Access: the hospital approach and the pharmacotherapeutics guide system.
Speaker: Arístides de León
Institution: Responsible for pharmacotherapeutic management and secretary of the Clinical Trials Commission of the Hospital de la Candelaria de Tenerife.
Names: Raquel Carnero Gómez
Institution: University of Salamanca, Spain.